Medication info
Daewoong Bio Atorvastatin Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Daewoong Bio Atorvastatin Tablet 10 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201307002 · Approved 2013.04.19 · Insurance code 694000560

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular disease (including myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. If LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular disease (including myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • increased serum triglycerides
  • familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular disease. It particularly lowers the risk of myocardial infarction and stroke in adults over 55 years of age with multiple risk factors such as smoking, hypertension, and low HDL cholesterol, as well as in patients with type 2 diabetes. It also reduces the risk of hospitalization due to myocardial infarction, stroke, vascular surgery, and congestive heart failure in adults who already have coronary artery disease. For the treatment of hyperlipidemia, it decreases LDL cholesterol and total cholesterol in patients with primary hypercholesterolemia and dyslipidemia while increasing HDL cholesterol. It is especially effective in patients who do not respond to dietary therapy. It is also used as an adjunctive therapy for the treatment of familial hypercholesterolemia in children aged 10 to 17 years. This medication effectively improves cardiovascular diseases and hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after treatment initiation and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. If LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscular symptoms, so if muscle pain or weakness is severe or if creatine kinase levels significantly increase, the patient should stop taking the medication immediately and consult a doctor. This medication can affect liver function, so it should not be used in patients with liver disease or elevated liver function test results, and regular liver function tests should be performed during treatment. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraception while on this medication. This medication should not be used in children under 10 years old, and elderly patients or those with reduced kidney function are at higher risk for myopathy and should exercise caution. There are many drug interactions, so it is imperative to inform the doctor, especially when used in conjunction with certain antibiotics, antifungals, HIV medications, and some lipid-lowering agents, as dose adjustments or cessation may be needed. If fever, weakness, or unexplained muscle pain occurs during treatment, healthcare professionals should be notified immediately, and if severe skin rash or allergic reactions occur, the medication should be discontinued. The consumption of grapefruit juice should be avoided as it may increase blood concentration levels of the medication. There is no specific antidote for overdose, so treatment should be symptomatic, and it is important to keep this medication out of the reach of children.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 155 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • neurogenic edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urine leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • duodenal ulcer
  • dysphagia
  • melena
  • gingival hemorrhage
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • difficulty breathing
  • asthma
  • sensory abnormalities
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • heightened tension
  • muscle disease
  • arthritis
  • bursitis
  • synovitis
  • myasthenia
  • contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequency
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breasts
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urge incontinence
  • abnormal ejaculation
  • uterine bleeding
  • dark urine
  • hypothermia
  • hypertriglyceridemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hypertrophy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the efficacy of the medication.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.